(Q34467551)

English

Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Gerhardt Attard

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Arie S Belldegrun

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Johann S de Bono

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1241-1246

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

The evolving role of estrogen therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

The androgen axis in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Corticosteroid-induced inhibition of adrenal androgen production in selected patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Possible mechanism of dexamethasone therapy for prostate cancer: Suppression of circulating level of interleukin‐6

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

The regulation of 17,20 lyase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

In vitro and in vivo models for the evaluation of potent inhibitors of male rat 17alpha-hydroxylase/C17,20-lyase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05821.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2005.05821.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34467551&oldid=1855918801"